Nurix Therapeutics Newsroom

Stifel Nicolaus Sticks to Their Buy Rating for Nurix Therapeutics (NRIX)

TipRanksJul 16 22:17 ET

JPMorgan Adjusts Price Target on Nurix Therapeutics to $34 From $31, Maintains Overweight Rating

MT NewswiresJul 15 10:37 ET

Nurix Therapeutics Analyst Ratings

BenzingaJul 15 10:03 ET

Barclays Sticks to Its Buy Rating for Nurix Therapeutics (NRIX)

TipRanksJul 14 21:39 ET

Needham Adjusts Price Target on Nurix Therapeutics to $29 From $31, Maintains Buy Rating

MT NewswiresJul 12 10:20 ET

Nurix Therapeutics (NRIX) Receives a Buy From Wells Fargo

TipRanksJul 12 09:00 ET

Piper Sandler Remains a Buy on Nurix Therapeutics (NRIX)

TipRanksJul 12 06:38 ET

Nurix Therapeutics Analyst Ratings

BenzingaJul 12 06:14 ET

Nurix Therapeutics Analyst Ratings

BenzingaJun 27 10:30 ET

HC Wainwright & Co. Maintains Buy on Nurix Therapeutics, Raises Price Target to $26

BenzingaJun 18 06:10 ET

Nurix Therapeutics Analyst Ratings

BenzingaJun 17 05:50 ET

Nurix Therapeutics Analyst Ratings

BenzingaJun 5 10:07 ET

Nurix Therapeutics Gains Buy Rating Amid Strong Clinical Advances for CLL Drug NX-5948

TipRanksMay 16 04:21 ET

Nurix Therapeutics Analyst Ratings

BenzingaMay 14 12:08 ET

Analysts Are Bullish on Top Healthcare Stocks: Unicycive Therapeutics (UNCY), Nurix Therapeutics (NRIX)

TipRanksMay 14 11:45 ET

Nurix Therapeutics Analyst Ratings

BenzingaMay 14 06:04 ET

Analysts' Top Healthcare Picks: Evolent Health (EVH), Nurix Therapeutics (NRIX)

TipRanksApr 17 07:25 ET

Analysts Offer Insights on Healthcare Companies: Evogene (EVGN), Edwards Lifesciences (EW) and Nurix Therapeutics (NRIX)

TipRanksApr 11 08:02 ET

RBC Lifts Price Target on Nurix Therapeutics to $23 From $22, Keeps Outperform Rating, Speculative Risk Qualifier

MT NewswiresApr 11 06:22 ET

Nurix Therapeutics Analyst Ratings

BenzingaApr 11 04:41 ET